Clinical Trials at Urology of VirginiaOur staff’s experienced investigators and certified clinical research coordinators closely monitor participating patients during the course of a study period. All clinical trials are conducted according to the principles of Good Clinical Practice (GCPs) as mandated by the FDA.
For questions and information about our clinical trials, please contact us at research@urologyofva.net
There is a new research study in Virginia Beach for men living with BPH (enlarged prostate).
No cost to participate. Learn more. 757-452-3463.
- Participants have access to advanced medications or devices before they become available to the public.
- Clinical study procedures may be provided to you at no cost.
- Participants often express enthusiasm for contributing to medical science.
- Today’s clinical research can positively impact future generations.
Enrolling Clinical Studies at Urology of Virginia
CG Oncology PIVOT-006: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Phase 3, open-label, randomized trial designed to evaluate the recurrence free survival of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by observation for the treatment of participants with intermediate risk non-muscle invasive bladder cancer.
Get detailed information about this clinical trial»
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with BCG, compared to BCG monotherapy, in participants with HR NMIBC that is either persistent or recurrent following adequate BCG induction (Cohort A), or that is naïve to BCG treatment (Cohort B).
Get detailed information about this clinical trial»
Ferring ABLE-32: Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Study designed to evaluate the efficacy of nadofaragene firadenovac vs. observation in subjects with non-muscle invasive bladder cancer.
Get detailed information about this clinical trial»
Ferring ABLE-41: ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States
Multi-center, prospective non-interventional study to collect data on the early use of ADSTILADRIN in the US. Data will be collected from participants, caregivers and prescribing physicians in a real-world setting.
Expected Management
Canary PASS:
A multicenter, prospective active surveillance study with selective intervention in patients with previously untreated, clinically localized prostate cancer at diagnosis. The objective is to discover and confirm biomarkers that predict aggressive disease.
Hormone Therapy (ADT)/ Other Treatments
Debiopharma Debio 4228: A Dose Finding Study of Debio 4228 in Participants with Locally Advanced/Metastatic Prostate Cancer
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Get detailed information about this clinical trial»
Francis Medical VAPOR2: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer
The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device (“Vanquish”) in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.
Get detailed information about this clinical trial»
Metastatic disease: Cancer that has spread to other areas
Debiopharma Debio 4228: A Dose Finding Study of Debio 4228 in Participants with Locally Advanced/Metastatic Prostate Cancer
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Get detailed information about this clinical trial»
Dendreon ProvONE: Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T (ProvONE)
A multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).
BPH (Enlarged Prostate)
Prodeon EXPANDER-2: A Randomized Study to Evaluate the Safety and Efficacy of the Urocross(TM) Expander System and Retrieval Sheath
To demonstrate the safety and efficacy of the Urocross Expander System/Retrieval Sheath and the procedure to treat patients with symptomatic Benign Prostatic Hyperplasia (BPH).
Get detailed information about this clinical trial»
Hypogonadism/Low Testosterone
No Enrolling Studies at This Time
Incontinence
No Enrolling Studies at This Time
Interstitial Cystitis
No Enrolling Studies at This Time
Nocturia
No Enrolling Studies at This Time
Pelvic Organ Prolapse
No Enrolling Studies at This Time
Stone Disease
AVVIO ELS: Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
The purpose of this trial is to demonstrate the safety and efficacy of the Enhanced Lithotripsy System (ELS) in patients with a urinary stone within the ureter (proximal, middle, or distal).
Urethral Stricture
No Enrolling Studies at This Time